Teva Pharmaceutical Valuation
| TEVA Stock | ILA 4,978 28.00 0.57% |
At this time, the company appears to be undervalued. Teva Pharmaceutical has a current Real Value of 5709.73 per share. The regular price of the company is 4978.0. Our model measures the value of Teva Pharmaceutical from inspecting the company fundamentals such as Return On Equity of -0.24, shares outstanding of 1.11 B, and Operating Margin of 0.18 % as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend taking in undervalued stocks and trading overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Undervalued
Today
Please note that Teva Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of Teva Pharmaceutical is based on 3 months time horizon. Increasing Teva Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Teva Pharmaceutical Industries is useful when determining the fair value of the Teva stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Teva Pharmaceutical. Since Teva Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Teva Stock. However, Teva Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4978.0 | Real 5709.73 | Hype 4978.0 | Naive 4762.03 |
The real value of Teva Stock, also known as its intrinsic value, is the underlying worth of Teva Pharmaceutical Company, which is reflected in its stock price. It is based on Teva Pharmaceutical's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Teva Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Teva Pharmaceutical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Teva Pharmaceutical Industries helps investors to forecast how Teva stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Teva Pharmaceutical more accurately as focusing exclusively on Teva Pharmaceutical's fundamentals will not take into account other important factors: Teva Pharmaceutical Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Teva Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Teva Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Teva Pharmaceutical competition to find correlations between indicators driving Teva Pharmaceutical's intrinsic value. More Info.Teva Pharmaceutical Industries is currently regarded as top stock in price to book category among related companies. It is currently regarded as top stock in price to sales category among related companies fabricating about 1.97 of Price To Sales per Price To Book. Comparative valuation analysis is a catch-all model that can be used if you cannot value Teva Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Teva Pharmaceutical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Teva Pharmaceutical's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Teva Pharmaceutical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Teva Pharmaceutical and how it compares across the competition.
About Teva Pharmaceutical Valuation
The stock valuation mechanism determines the current worth of Teva Pharmaceutical Industries on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Teva Pharmaceutical Industries. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Teva Pharmaceutical based exclusively on its fundamental and basic technical indicators. By analyzing Teva Pharmaceutical's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Teva Pharmaceutical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Teva Pharmaceutical. We calculate exposure to Teva Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Teva Pharmaceutical's related companies.Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel. TEVA PHARMA is traded on Tel Aviv Stock Exchange in Israel.
8 Steps to conduct Teva Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Teva Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Teva Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Teva Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Teva Pharmaceutical's revenue streams: Identify Teva Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Teva Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Teva Pharmaceutical's growth potential: Evaluate Teva Pharmaceutical's management, business model, and growth potential.
- Determine Teva Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Teva Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharmaceutical Industries. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Teva Stock analysis
When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |